![PDF) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing PDF) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing](https://0.academia-photos.com/attachment_thumbnails/68208414/mini_magick20210720-4145-16bj233.png?1626781379)
PDF) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing
Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients
![Comorbidity and physical function: variables associated with BASFI in... | Download Scientific Diagram Comorbidity and physical function: variables associated with BASFI in... | Download Scientific Diagram](https://www.researchgate.net/publication/332734600/figure/tbl1/AS:764313937661952@1559238051593/Comorbidity-and-physical-function-variables-associated-with-BASFI-in-patients-with-AS.png)
Comorbidity and physical function: variables associated with BASFI in... | Download Scientific Diagram
![Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis](https://www.frontiersin.org/files/Articles/856654/fmed-09-856654-HTML/image_m/fmed-09-856654-g001.jpg)
Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
![PDF) The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis PDF) The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis](https://i1.rgstatic.net/publication/304008906_The_Minimum_Clinically_Important_Improvement_and_Patient-acceptable_Symptom_State_in_the_BASDAI_and_BASFI_for_Patients_with_Ankylosing_Spondylitis/links/576a314208ae1a43d23a3fd4/largepreview.png)
PDF) The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
![Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-009-1313-9/MediaObjects/296_2009_1313_Fig1_HTML.gif)
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink
![Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-009-1313-9/MediaObjects/296_2009_1313_Fig2_HTML.gif)
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink
![Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/47/1/35/F1.large.jpg)